Developmental changes in pharmacokinetics of recombinant human insulin- like growth factor-I in rats

Research Communications in Molecular Pathology and Pharmacology

Volumn 97, Issue 2, 1997, Pages 115-124

  Higaki, Kazutaka ^a   Matsumoto, Yukihiro ^a   Fujimoto, Rika ^a   Kurosaki, Yuji ^a   Kimura, Toshikiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BODY GROWTH; DRUG CLEARANCE; DRUG ELIMINATION; DWARFISM; GROWTH HORMONE DEFICIENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; AREA UNDER CURVE; CHROMATOGRAPHY, GEL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAVENOUS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 0030921708     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bach, M. A., Chin, E. and Bondy, C. A. (1994). The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 79: 1040-1045.
2. Backeljauw, P. F. and Underwood, L. E. (1996). Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome. J. Clin. Endocrinol. Metab. 81: 3312-3317.
3. Carel, J. C., Chaussain, J. L., Chatelain, P. and Savage, M. O. (1996). Growth hormone insensitivity syndrome (Laron syndrome) : Main characteristics and effects of IGF-I treatment. Diabetes Metab. 22: 251-256.
4. Drakenberg, K., Östenson, C.-G. and Sara, V. (1990). Circulating forms and biological activity of intact and truncated insulin-like growth factor I in adult and neonatal rats. Acta Endocrinol. 123: 43-50.
5. Dunger, D. B. (1995). Insulin and insulin-like growth factors in diabetes mellitus. Arch. Dis. Child. 72: 469-477.
6. Froesch, E. R., Bianda, T. and Hussain, M. A. (1996). Insulin-like growth factor-I in the therapy of non-insulin-dependent diabetes mellitus and insulin resistance. Diabetes Metab. 22: 261-267.
7. Giannella-Neto, D., Cavaleiro, A. M., Sadoyama, R., Wajchenberg, B. L. and Spencer, E. M. (1990). Evaluation of a radioimmunoassay for somatomedin-C/insulin-like growth factor I (Sm-C/IGF-I) in human plasma. Clin. Chim. Acta 188: 253-260.
8. Graubert, M. D., Goldstein, S. and Phillips, L. S. (1991). Nutrition and somatomedin XXVII. Total and free IGF-I and IGF binding proteins in rats with streptozocin-induced diabetes. Diabetes 40: 959-965.
9. Hofert, J. F., Goldstein, S. and Phillips, L. S. (1989). Glucocorticoid effects on IGF-1/somatomedin-C and somatomedin inhibitor in streptozotocin-diabetic rats. Metabolism 38: 594-600.
10. Humbel, R. E. (1990). Insulin-like growth factors I and II. Eur. J. Biochem. 190: 445-462.
11. Kimura, T., Kanzaki, Y., Matsumoto, Y., Mandai, M., Kurosaki, Y. and Nakayama, T. (1994). Disposition of recombinant human insulin-like growth factor-I in normal and hypophysectomized rats. Biol. Pharm. Bull. 17: 310-315.
12. Lassarre, C., Hardouin, S., Daffow, F., Forestier, F., Frankenne, F. and Binoux, M. (1991). Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr. Res. 29: 219-225.
13. Lee, C. Y., Bazer, F. W., Etherton, T. D. and Simmen, F. A. (1991). Ontogeny of insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in porcine serum during fetal and postnatal development. Endocrinology 128: 2336-2344.
14. Lewitt, M. S., Saunders, H. and Baxter, R. C. (1993). Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. Endocrinology 133: 1797-1802.
15. Liu, F., Powell, D. R., Styne, D. M. and Hintz, R. L. (1991). Insulin-like growth factors (IGFs) and IGF-binding proteins in the developing rhesus monkey. J. Clin. Endocrinol. Metab. 72: 905-911.
16. Schalch, D. S., Turman, N. J., Marcsisin, V. S., Heffernan, M. and Guler, H.-P. (1993). Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus. J. Clin. Endocrinol. Metab. 77: 1563-1568.
17. Styne, D. M. (1991). Serum insulin-like growth factor 1 concentrations in the developing rhesus monkey. J. Med. Primatol. 20: 334-337.
18. Suzuki, K., Hashimoto, K., Asada, T., Nakanishi, S., Horiai, H. and Niwa, M. (1987). Measurement of IGF-I/somatomedin-C in plasma by radioimmunoassay (RIA). Study on RIA using antiserum and monoclonal antibody against recombinant IGF-I. Clin. Pharmacol. (Japan) 35: 853-858.
19. Usala, A.-L., Madigan, T., Burguera, B., Cefalu, W., Sinha, M. K., Powell, J. G. and Usala, S. J. (1994). High dose iv, but not low dose subcutaneous, insulin-like growth factor-I therapy induces sustained insulin sensitivity in severely resistant type I diabetes mellitus. J. Clin. Endocrinol. Metab. 79: 435-440.
20. Yamaoka, K., Nakagawa, T. and Uno, T. (1978). Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6: 547-558.